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Maternal Germline Mosaicism in Dominant Dystrophic
Epidermolysis Bullosa
To the Editor:
The dystrophic form of epidermolysis bullosa (DEB) can be
inherited in both an autosomal dominant or a recessive fashion
(Christiano and Uitto, 1996). The recessive form can range from a
very severe condition (Hallopeau-Siemens DEB) to a relatively
mild disease, clinically indistinguishable from the dominantly
inherited mild form of DEB, (DDEB) (Fine et al, 2000). A new
case of mild DEB, therefore, always presents the problem of
differentiating recessively inherited vs. dominantly inherited DEB
due either to de novo mutations or to germline mosaicism. The
latter was previously suggested in the junctional form of
epidermolysis bullosa, which originates from mutations in the
genes encoding laminin 5 (Kivirikko et al, 1996), but has not been
demonstrated in the case of DEB.
Here, we report a family with one child affected by mild DEB.
At birth, blistering and denuded areas were present together with
the syndactyly of the second and third toes. By the age of 11 mo,
blistering was signi®cantly reduced but the blisters healed with
hyperpigmented and hypopigmented scars and milia. Both parents
and an older sibling were clinically unaffected, and there was no
family history of consanguinity or of a blistering disorder or skin
fragility.
Screening for mutations in the COL7A1 gene in the patient
using previously described techniques (Christiano et al, 1997)
revealed a single glycine substitution in the triple helical domain of
the type VII collagen gene (G2003R), which has previously been
associated with Bart's syndrome, a form of DDEB (Christiano et al,
1996). This mutation, however, was not found in the peripheral
blood DNA of the clinically unaffected parents and the sibling
(Fig 1). As nonpaternity based on parental interviews was unlikely,
we concluded that the mutation was most likely a de novo event in
the patient, and would be associated with little risk of recurrence.
Nevertheless, the parents were appropriately counselled that the
possibility of having another affected child existed, if the mutation
existed as a germline mosaic transmitted from either parent ± a
possibility that was considered remote.
Shortly after completing the mutation analysis, the mother
became pregnant and the parents requested prenatal diagnosis.
DNA isolated from the amniotic ¯uid sample was used as template
for polymerase chain reaction ampli®cation and automated
sequencing. Unexpectedly, the mutation G2003R was also present
in the fetus, suggesting that the initial occurrence was in fact not a
de novo event. We could only explain the second occurrence of the
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Figure 1. Haplotype analysis of a pedigree with DEB. The ®gure
shows the haplotype of the family members, listed according to the
microsatellite markers indicated on the left. The mutation G2003R is
also listed. The ®gure demonstrates that all three offspring (individuals II-
1 to II-3) carry the same maternal (individual I-2) chromosome 3
haplotype. The two affected individuals (individuals II-2 and II-3) display
different paternal chromosome 3 haplotype. The mutation G2003 is
present only in individuals II-2 and II-3 (gray shading), suggesting that it
is only contained in a percentage of the maternal chromosomes.
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identical mutation in this family by invoking the possibility of
germline mosaicism. To further investigate the parental transmis-
sion of the mutation, we performed haplotype analysis using
chromosome 3 microsatellite markers (Fig 1), synthesized based on
publicly available oligonucleotide sequences (Cooperative Human
Linkage Center and Genome Database). Polymerase chain reaction
products containing microsatellite markers for chromosome 3 were
analyzed on a 6% nondenaturing polyacrylamide gel. We deter-
mined that all three offspring carried the same maternal chromo-
some 3 haplotype. The clinically unaffected sister of the patient and
the affected fetus shared the same paternal chromosome; however,
the patient carried the other paternal chromosome. Thus, we
concluded that the mutation is most likely present in a percentage
of cells in the germline of the mother.
To our knowledge, this study represents the ®rst documented
case of germline mosaicism in epidermolysis bullosa and serves as a
reminder that germline mosaicism should be considered in every
case when a mutation is found in the offspring but not in the
parents. In the event of a de novo mutation, the family can be
counselled that the likelihood of having another affected child is the
same as in the general population. In the case of germline
mosaicism, however, the likelihood of having another affected
child is much higher, depending on the ratio of mutant to wild-
type germ cells. This possibility has a signi®cant impact on genetic
counselling, and unfortunately, exact determination of the trans-
mitting parent is not always possible. In the case of paternal
transmission, a semen sample can be used for further studies to
determine the percentage of mutant germ cells, and thus calculate
an accurate risk of recurrence for the family. These ®ndings
heighten our awareness of the existence of unusual modes of
inheritance in epidermolysis bullosa, which should be taken into
account when counselling families about the recurrence risk for
future offspring.
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